NR4A1 and breast carcinoma: The luminal A subtype-specific prognostic effect of THRα1 supports the data published by12 and suggests that T3 acting through THR signaling increases proliferation and enhances estrogen-mediated growth of hormone receptor positive breast cancer cells.